Expression of Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases, and Interleukins in Vertebral Cartilage Endplate

被引:39
|
作者
Zhang, Jian-feng [1 ]
Wang, Gang-liang [1 ]
Zhou, Zhi-jie [1 ]
Fang, Xiang-qian [1 ]
Chen, Shuai [1 ]
Fan, Shun-wu [1 ]
机构
[1] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Orthopaed, Med Coll, Hangzhou, Zhejiang, Peoples R China
关键词
Cartilage endplate; Degenerative disc disease; Interleukins; MMP; TIMP; NECROSIS-FACTOR-ALPHA; LOW-BACK-PAIN; OSTEOARTHRITIS; RECEPTOR; GENE; MODULATION; ADAMTS-4;
D O I
10.1111/os.12409
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Objective Methods Turnover of cartilage endplate extracellular matrix (ECM) may play an important role in disc degeneration and low back pain (LBP). However, the expression pattern of pro-inflammatory factors, matrix metalloproteinases (MMP), and tissue inhibitors of metalloproteinases (TIMP) in the cartilage endplates (CEP) of intervertebral discs (IVD) is not understood. We aimed to examine the transcriptional levels of MMP, TIMP, and interleukins (IL), and the correlations between them. Thirty degenerated cartilage endplate samples from patients with LBP who underwent lumbar fusion surgery were included in the degenerated group. Ten patients without LBP history who underwent lumbar surgery because of vertebral burst fractures were included in the control group. The degenerative severity of the samples was evaluated by MRI, and hematoxylin-eosin and safranin O-fast green (SO-FG) staining. Real-time polymerase chain reaction (RT-PCR) was used to detect the mRNA levels of MMP-1, MMP-3, MMP-9, MMP-13, TIMP-1, TIMP-2, TIMP-3, IL-1 alpha, IL-1 beta, and IL-6. The correlations between the levels of these genes were tested using Spearman's rho test. Results Conclusion Hematoxylin-eosin and SO-FG staining confirmed a decrease in cell number and proteoglycans in the degenerated cartilage endplate. MRI showed significant signal changes in degenerated cartilage endplates. Patients in the degenerated group showed a higher rate of endplate Modic changes when compared with the control group. MMP-3, MMP-9, TIMP-3, IL-1 alpha, and IL-1 beta were elevated with statistical significance, while MMP-1, MMP-13, TIMP-1, TIMP-2, and IL-6 were changed without statistical significance or remained unchanged. Expression of MMP-3 was positively correlated with IL-1 alpha (Spearman coefficient, 0.486; P < 0.05); expression of TIMP-3 was positively correlated with MMP-9, IL-1 alpha, and IL-1 beta (Spearman coefficient, 0.577, 0.407, and 0.571, respectively; P < 0.05). MMP-3, MMP-9, TIMP-3, IL-1 alpha, and IL-1 beta may play a role in the process of cartilage endplate degeneration. MMP-3 may be regulated by IL-1 alpha, and TIMP-3 might be associated with MMP-9 and regulated by IL-1 alpha and IL-1 beta.
引用
收藏
页码:306 / 311
页数:6
相关论文
共 50 条
  • [41] Matrix metalloproteinases and tissue inhibitors of metalloproteinases - Structure, function, and biochemistry
    Visse, R
    Nagase, H
    CIRCULATION RESEARCH, 2003, 92 (08) : 827 - 839
  • [42] Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue
    Kubota, T
    Nomura, T
    Takahashi, T
    Hara, K
    ARCHIVES OF ORAL BIOLOGY, 1996, 41 (03) : 253 - 262
  • [43] Metalloproteinases and tissue inhibitors of metalloproteinases
    Masakazu Toi
    Shinsuke Ishigaki
    Takeshi Tominaga
    Breast Cancer Research and Treatment, 1998, 52 : 113 - 124
  • [44] Metalloproteinases and tissue inhibitors of metalloproteinases
    Toi, M
    Ishigaki, S
    Tominaga, T
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 113 - 124
  • [45] Tissue inhibitors of matrix metalloproteinases in cancer
    Blavier, L
    Henriet, P
    Imren, S
    DeClerck, YA
    INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 : 108 - 119
  • [46] Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling
    Li, YY
    McTiernan, CF
    Feldman, AM
    CARDIOVASCULAR RESEARCH, 2000, 46 (02) : 214 - 224
  • [47] Expression of matrix: Metalloproteinases and tissue inhibitors of metalloproteinases (TIMPs) in reactive and neoplastic lymphoid cells.
    Lim, MS
    Mansoor, A
    Ptaszynski, K
    Wang, J
    Fukushima, P
    StetlerStevenson, WG
    StetlerStevenson, M
    BLOOD, 1995, 86 (10) : 722 - 722
  • [48] Matrix metalloproteinases and their tissue inhibitors in endocrinology
    Salamonsen, LA
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1996, 7 (01): : 28 - 34
  • [49] Expression and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases as a prognostic factor in advanced colorectal carcinomas
    Ogura, E
    Senzaki, H
    Kiyozuka, Y
    Takada, H
    Hioki, K
    Tsubura, A
    ONCOLOGY REPORTS, 1997, 4 (04) : 701 - 705
  • [50] Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
    Hou, Chun
    Miao, Yong
    Wang, Xue
    Chen, Chaoyue
    Lin, Bojie
    Hu, Zhiqi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (01) : 231 - 237